# Cataract DME - Peri vs. Intraop

> **NCT03920878** · PHASE2 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Diabetic Macular Edema
- Cataract

## Interventions

- **DRUG:** Aflibercept injected Pre- and Post-operatively
- **DRUG:** Aflibercept injected intraoperatively

## Key facts

- **NCT ID:** NCT03920878
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study team was unable to secure sufficient funding and administrative support.
- **Last updated:** 2020-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920878, "Cataract DME - Peri vs. Intraop". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03920878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*